See other bills
under the
same topic
                                                      PRINTER'S NO. 1724

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 1377 Session of 2007


        INTRODUCED BY M. SMITH, MAHER, BRENNAN, COHEN, DePASQUALE,
           EVERETT, GEIST, GIBBONS, GRELL, GRUCELA, HARPER, HENNESSEY,
           HESS, HORNAMAN, JAMES, JOSEPHS, M. KELLER, KULA, MANN,
           PALLONE, RAPP, READSHAW, SIPTROTH, SOLOBAY, R. STEVENSON,
           WAGNER, J. WHITE, CALTAGIRONE, MYERS AND COSTA, MAY 29, 2007

        REFERRED TO COMMITTEE ON EDUCATION, MAY 29, 2007

                                     AN ACT

     1  Amending the act of March 10, 1949 (P.L.30, No.14), entitled "An
     2     act relating to the public school system, including certain
     3     provisions applicable as well to private and parochial
     4     schools; amending, revising, consolidating and changing the
     5     laws relating thereto," further providing for possession and
     6     use of asthma inhalers.

     7     The General Assembly of the Commonwealth of Pennsylvania
     8  hereby enacts as follows:
     9     Section 1.  Section 1414.1 of the act of March 10, 1949
    10  (P.L.30, No.14), known as the Public School Code of 1949, added
    11  November 30, 2004 (P.L.1471, No.187), is amended to read:
    12     Section 1414.1.  Possession and Use of [Asthma Inhalers]
    13  Allergy Medicines by School-age Children.--(a)  Each school
    14  entity shall develop a written policy to allow for the
    15  possession and self-administration by children of school age of
    16  an asthma inhaler, epinephrine auto-injector and the prescribed
    17  medication to be administered thereby in a school setting. A
    18  school setting shall include, but not be limited to, the pupil's


     1  school, school-sponsored transportation or any activity, event
     2  or program sponsored by or in which the pupil's school is
     3  participating.
     4     (b)  The policy under this section shall require a child of
     5  school age that desires to possess and self-administer an asthma
     6  inhaler or epinephrine auto-injector in a school setting to
     7  demonstrate the capability for self-administration and for
     8  responsible behavior in the use thereof and to notify the school
     9  nurse immediately following each use of an asthma inhaler or
    10  epinephrine auto-injector. The school entity shall develop a
    11  system whereby the child may verify to the school nurse that the
    12  child is capable of self-administration and has permission for
    13  carrying and taking the medication through the use of the asthma
    14  inhaler or epinephrine auto-injector. The school entity shall
    15  also restrict the availability of the asthma inhaler,
    16  epinephrine auto-injector and the prescribed medication
    17  contained therein from other children of school age, with
    18  immediate confiscation of [both] the asthma inhaler, epinephrine
    19  auto-injector and the medication and loss of privileges if the
    20  school policies are abused or ignored.
    21     (c)  The policy under this section may include the following:
    22     (1)  The requirement of a written statement from the
    23  physician, certified registered nurse practitioner or physician
    24  assistant that provides the name of the drug, the dose, the
    25  times when the medication is to be taken and the diagnosis or
    26  reason the medicine is needed unless the reason should remain
    27  confidential. The physician, certified registered nurse
    28  practitioner or physician assistant shall indicate the potential
    29  of any serious reaction that may occur to the medication, as
    30  well as any necessary emergency response. The physician,
    20070H1377B1724                  - 2 -     

     1  certified registered nurse practitioner or physician assistant
     2  shall state whether the child is qualified and able to self-
     3  administer the medication.
     4     (2)  The requirement of a written request from the parent or
     5  guardian that the school entity comply with the order of the
     6  physician, certified registered nurse practitioner or physician
     7  assistant. The parent's note shall include a statement relieving
     8  the school entity or any school employe of any responsibility
     9  for the benefits or consequences of the prescribed medication
    10  when it is parent-authorized and acknowledging that the school
    11  entity bears no responsibility for ensuring that the medication
    12  is taken.
    13     (3)  The ability of the school entity to reserve the right to
    14  require a statement from the physician, certified registered
    15  nurse practitioner or physician assistant for the continued use
    16  of any medication beyond a specified time period. The school
    17  entity may also require updated prescription and parental
    18  approval on an annual basis from the pupil.
    19     (c.1)  A school district, nonpublic school, member of a
    20  school board, director or officer of a nonpublic school or
    21  employe of a school district or nonpublic school is not liable
    22  for damages in a civil action for injury, death or loss to
    23  person or property allegedly arising from a pupil being
    24  prohibited by an employe of the school or school district from
    25  using an inhaler or epinephrine auto-injector because of the
    26  employe's reasonable belief formed after a reasonable and
    27  ordinary inquiry that the conditions prescribed in subsection
    28  (c) had not been satisfied. A school district, nonpublic school,
    29  member of a school board, director or officer of a nonpublic
    30  school, or employe of a school district or nonpublic school is
    20070H1377B1724                  - 3 -     

     1  not liable for damages in a civil action for injury, death or
     2  loss to person or property allegedly arising from a pupil being
     3  permitted by an employe of the school or school district to use
     4  an inhaler or epinephrine auto-injector because of the employe's
     5  reasonable belief formed after a reasonable and ordinary inquiry
     6  that the conditions prescribed in subsection (c) had been
     7  satisfied. This subsection does not eliminate, limit or reduce
     8  any other immunity or defense that a school district, member of
     9  a school board, director or employe of a school district may
    10  have under the law of this Commonwealth.
    11     (c.2)  A principal or other chief administrator who is aware
    12  that a pupil is in possession of an inhaler or epinephrine auto-
    13  injector pursuant to this section shall notify each of the
    14  pupil's classroom teachers of that fact and of the provisions of
    15  this section.
    16     (d)  As used in this section, "school entity" means a school
    17  district, intermediate unit or area vocational-technical school.
    18     Section 2.  This act shall take effect in 60 days.








    D17L24JKL/20070H1377B1724        - 4 -